They number 15,000, the colony of zebrafish in the Core Zebrafish Facility Ghent at the site of UZ Gent. They are nurtured and cared for under optimum conditions as laboratory animals by the researchers of the Centre for Medical Genetics. “But research into genetic disorders is not all we do here,” professor Paul Coucke emphasises.
Good news for sports fanatics, the summer of sports is not over yet! Our Belgian athletes will soon be competing at the Paralympic Games. Alumna Inge Bru, specialist in physical medicine and rehabilitation at Ghent University Hospital, accompanies them in Paris.
Creating new pieces of bone, muscle, skin or fat with a 3D printer to heal injuries. Sounds futuristic? The first steps are already being taken today! We spoke with plastic surgeon and professor Phillip Blondeel about his research into tissue engineering.
Sunshine and holidays equal a tanned skin for many. But we need to adjust our ideas about tanning, according to dermatologists Lieve Brochez and Isabelle Hoorens. Our behavior towards the sun and UV will cause more and more cases of skin cancer in the coming years.
The doping controls at the upcoming Olympic and Paralympic Games will again have a Ghent connection. The doping control lab of Ghent University, DoCoLab for short, is sending a team of researchers to Paris to help check many thousands of samples. Peter Van Eenoo, head of the lab, professor and cycling fan, will be part of that team: "We won't have lots of free time, but I do hope to catch some of the cycling (laughs)."
Marianne De Backer is a heavyweight in the world of biotechnology. Today she is CEO of Vir Biotechnology, a biotech company headquartered in Silicon Valley. She is a champion of women in leadership positions in this still male-dominated industry.
HIV, the virus that causes AIDS, surfaced in the eighties. Long gone are the times when the virus was a sure death sentence. Still, even after all these years the stubborn stigma that surrounds HIV persists. Why is that and what can be done about it?
Researchers around the world are looking for innovative ways to detect and treat breast cancer. So are experimental oncologist An Hendrix and medical oncologist Hannelore Denys, two top researchers from Ghent.
Imke Kissel researches unilateral vocal cord paralysis and wants to develop therapies tailored to the needs of patients.
Serhat Yildirim (26) just completed his final exams in medicine after which he will start at the prestigious Harvard University. He was admitted for the two-year master's degree in Global Health Delivery.
Do you suffer from hay fever? You are not alone: no less than 1 in 3 people worldwide have an allergy, particularly to pollen or dust mites. For people aged between 20 and 45 this amount is as much as 40%. “In fact, we expect this number to keep growing in the future”, predicts professor Philippe Gevaert (department of Head and Skin), clinical head of the Ear, Nose and Throat department at Ghent University Hospital. “But, don’t worry: a solution is on the way.”
Alzheimer’s disease, frontotemporal dementia and ALS are devastating neurodegenerative diseases with no prospect of recovery. Clinical geneticist, physician and Ghent University professor Bart Dermaut is making a breakthrough with his scientific research that could push future therapies in a new direction. This is partly thanks to donations and legacies from patients.
